4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0000950170-23-022548
Chief Financial Officer sold 347 shares at $8.78 ($3,047)
From the SEC's structured data for this filing
Trades in this filing
Trigilio Jeffrey · Chief Financial Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-05-12 | Sale : show line 1 in the form | −347 | $8.78 | $3,047 | 86,940 | D |
| Open-market sales · 347 sh · avg $8.78 · $3,047 | ||||||
Loading xslF345X04/ownership.xml…